Xia Gan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xia Gan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bingyao Huang
Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China
1 shared publication - Humu Lu
Guangxi University of Chinese Medicine
1 shared publication - Xiaowei Luo
Guangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China
1 shared publication - Xueni Wang
Guangxi Engineering Research Center for High-Value Utilization of Guangxi-Produced Authentic Medicinal Herbs, Institute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning 530200, China
1 shared publication - Yanting Zhang
Guangxi University of Chinese Medicine
1 shared publication - Yonghong Liu
South China Sea Institute of Oceanology, Chinese Academy of Sciences
1 shared publication
Latest Publications
- 29 October 2022
- Published by ACG Publications in Records of Natural Products
- Vol. 17 (1) , 165-169
Bioactive Alkaloids from the Beibu Gulf Coral-associated Fungus Acremonium sclerotigenum GXIMD 02501
The Beibu Gulf represents an underexplored reservoir of marine micro-/organisms and secondary metabolites. Three uncommon 4-hydroxy-2-pyridone alkaloids and one phenazine alkaloid were obtained from the Beibu Gulf coral-associated fungus Acremonium sclerotigenum GXIMD 02501 via OSMAC approach. They were identified as campyridones D (1) and A (2), ilicicolin H (3), and phenazine-1-carboxylic acid (4), respectively, by spectroscopic analysis and comparison with literature values. All of them were evaluated for cytotoxic, anti-Vibrio, and NF-κB luciferase inhibitory activities. Compounds 2 and 3 showed cytotoxicity against two prostate cancer cell lines, with IC50 values of 17.6 ± 1.3 and 5.5 ± 1.2 μM for PC-3, while 25.4 ± 1.7 and 11.9 ± 1.3 μM for 22Rv1, respectively. Besides, compound 4 showed promising anti-Vibrio activity with MIC values of 0.047–0.067 mg/mL and also displayed inhibition of LPS-induced NF-κB activation at 10 μM.
- 29 October 2022
- Published by ACG Publications in Records of Natural Products
- Vol. 17 (1) , 165-169
Bioactive Alkaloids from the Beibu Gulf Coral-associated Fungus Acremonium sclerotigenum GXIMD 02501
The Beibu Gulf represents an underexplored reservoir of marine micro-/organisms and secondary metabolites. Three uncommon 4-hydroxy-2-pyridone alkaloids and one phenazine alkaloid were obtained from the Beibu Gulf coral-associated fungus Acremonium sclerotigenum GXIMD 02501 via OSMAC approach. They were identified as campyridones D (1) and A (2), ilicicolin H (3), and phenazine-1-carboxylic acid (4), respectively, by spectroscopic analysis and comparison with literature values. All of them were evaluated for cytotoxic, anti-Vibrio, and NF-κB luciferase inhibitory activities. Compounds 2 and 3 showed cytotoxicity against two prostate cancer cell lines, with IC50 values of 17.6 ± 1.3 and 5.5 ± 1.2 μM for PC-3, while 25.4 ± 1.7 and 11.9 ± 1.3 μM for 22Rv1, respectively. Besides, compound 4 showed promising anti-Vibrio activity with MIC values of 0.047–0.067 mg/mL and also displayed inhibition of LPS-induced NF-κB activation at 10 μM.